ActiTrexx GmbH

Startup

ActiTrexx, a designated spin-out of the University Medical Center Mainz, Germany, focuses on the development and commercialization of the cellular therapy ATreg for the treatment of patients after hematopoetic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GvHD).


Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

 

To speak


Ila Dickinson
ila.dickinson@terrapinn.com
+44 207 092 1150